The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Inosine Pranobex-Global Market Insights and Sales Trends 2025
Synopsis
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The global Inosine Pranobex market size is expected to reach US$ 234.5 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Inosine Pranobex in various end use industries. The expanding demands from the Immunomodulation, Antiviral and Other, are propelling Inosine Pranobex market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Syrup segment is estimated at % CAGR for the next seven-year period.
Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.
Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.
In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inosine Pranobex, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inosine Pranobex market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inosine Pranobex market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inosine Pranobex sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inosine Pranobex covered in this report include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex and Sanfer, etc.
The global Inosine Pranobex market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Alfasigma S.p.A.
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
Global Inosine Pranobex market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inosine Pranobex market, Segment by Type:
Tablet
Syrup
Global Inosine Pranobex market, by Application
Immunomodulation
Antiviral
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inosine Pranobex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inosine Pranobex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The global Inosine Pranobex market size is expected to reach US$ 234.5 million by 2029, growing at a CAGR of 2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Inosine Pranobex in various end use industries. The expanding demands from the Immunomodulation, Antiviral and Other, are propelling Inosine Pranobex market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Syrup segment is estimated at % CAGR for the next seven-year period.
Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.
Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.
In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inosine Pranobex, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inosine Pranobex market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inosine Pranobex market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inosine Pranobex sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inosine Pranobex covered in this report include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex and Sanfer, etc.
The global Inosine Pranobex market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Alfasigma S.p.A.
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
Global Inosine Pranobex market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inosine Pranobex market, Segment by Type:
Tablet
Syrup
Global Inosine Pranobex market, by Application
Immunomodulation
Antiviral
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Inosine Pranobex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Inosine Pranobex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Inosine Pranobex Market Overview
1.1 Inosine Pranobex Product Overview
1.2 Inosine Pranobex Market Segment by Type
1.2.1 Tablet
1.2.2 Syrup
1.3 Global Inosine Pranobex Market Size by Type
1.3.1 Global Inosine Pranobex Market Size Overview by Type (2018-2029)
1.3.2 Global Inosine Pranobex Historic Market Size Review by Type (2018-2023)
1.3.3 Global Inosine Pranobex Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Inosine Pranobex Sales Breakdown by Type (2018-2023)
1.4.2 Europe Inosine Pranobex Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Inosine Pranobex Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Inosine Pranobex Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Inosine Pranobex Sales Breakdown by Type (2018-2023)
2 Global Inosine Pranobex Market Competition by Company
2.1 Global Top Players by Inosine Pranobex Sales (2018-2023)
2.2 Global Top Players by Inosine Pranobex Revenue (2018-2023)
2.3 Global Top Players by Inosine Pranobex Price (2018-2023)
2.4 Global Top Manufacturers Inosine Pranobex Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inosine Pranobex Market Competitive Situation and Trends
2.5.1 Inosine Pranobex Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Inosine Pranobex Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inosine Pranobex as of 2022)
2.7 Date of Key Manufacturers Enter into Inosine Pranobex Market
2.8 Key Manufacturers Inosine Pranobex Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Inosine Pranobex Status and Outlook by Region
3.1 Global Inosine Pranobex Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Inosine Pranobex Historic Market Size by Region
3.2.1 Global Inosine Pranobex Sales in Volume by Region (2018-2023)
3.2.2 Global Inosine Pranobex Sales in Value by Region (2018-2023)
3.2.3 Global Inosine Pranobex Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Inosine Pranobex Forecasted Market Size by Region
3.3.1 Global Inosine Pranobex Sales in Volume by Region (2024-2029)
3.3.2 Global Inosine Pranobex Sales in Value by Region (2024-2029)
3.3.3 Global Inosine Pranobex Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Inosine Pranobex by Application
4.1 Inosine Pranobex Market Segment by Application
4.1.1 Immunomodulation
4.1.2 Antiviral
4.1.3 Other
4.2 Global Inosine Pranobex Market Size by Application
4.2.1 Global Inosine Pranobex Market Size Overview by Application (2018-2029)
4.2.2 Global Inosine Pranobex Historic Market Size Review by Application (2018-2023)
4.2.3 Global Inosine Pranobex Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Inosine Pranobex Sales Breakdown by Application (2018-2023)
4.3.2 Europe Inosine Pranobex Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Inosine Pranobex Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Inosine Pranobex Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Inosine Pranobex Sales Breakdown by Application (2018-2023)
5 North America Inosine Pranobex by Country
5.1 North America Inosine Pranobex Historic Market Size by Country
5.1.1 North America Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Inosine Pranobex Sales in Volume by Country (2018-2023)
5.1.3 North America Inosine Pranobex Sales in Value by Country (2018-2023)
5.2 North America Inosine Pranobex Forecasted Market Size by Country
5.2.1 North America Inosine Pranobex Sales in Volume by Country (2024-2029)
5.2.2 North America Inosine Pranobex Sales in Value by Country (2024-2029)
6 Europe Inosine Pranobex by Country
6.1 Europe Inosine Pranobex Historic Market Size by Country
6.1.1 Europe Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Inosine Pranobex Sales in Volume by Country (2018-2023)
6.1.3 Europe Inosine Pranobex Sales in Value by Country (2018-2023)
6.2 Europe Inosine Pranobex Forecasted Market Size by Country
6.2.1 Europe Inosine Pranobex Sales in Volume by Country (2024-2029)
6.2.2 Europe Inosine Pranobex Sales in Value by Country (2024-2029)
7 Asia-Pacific Inosine Pranobex by Region
7.1 Asia-Pacific Inosine Pranobex Historic Market Size by Region
7.1.1 Asia-Pacific Inosine Pranobex Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Inosine Pranobex Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Inosine Pranobex Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Inosine Pranobex Forecasted Market Size by Region
7.2.1 Asia-Pacific Inosine Pranobex Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Inosine Pranobex Sales in Value by Region (2024-2029)
8 Latin America Inosine Pranobex by Country
8.1 Latin America Inosine Pranobex Historic Market Size by Country
8.1.1 Latin America Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Inosine Pranobex Sales in Volume by Country (2018-2023)
8.1.3 Latin America Inosine Pranobex Sales in Value by Country (2018-2023)
8.2 Latin America Inosine Pranobex Forecasted Market Size by Country
8.2.1 Latin America Inosine Pranobex Sales in Volume by Country (2024-2029)
8.2.2 Latin America Inosine Pranobex Sales in Value by Country (2024-2029)
9 Middle East and Africa Inosine Pranobex by Country
9.1 Middle East and Africa Inosine Pranobex Historic Market Size by Country
9.1.1 Middle East and Africa Inosine Pranobex Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Inosine Pranobex Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Inosine Pranobex Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Inosine Pranobex Forecasted Market Size by Country
9.2.1 Middle East and Africa Inosine Pranobex Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Inosine Pranobex Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Newport Pharmaceuticals
10.1.1 Newport Pharmaceuticals Company Information
10.1.2 Newport Pharmaceuticals Introduction and Business Overview
10.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Newport Pharmaceuticals Inosine Pranobex Products Offered
10.1.5 Newport Pharmaceuticals Recent Development
10.2 Gedeon Richter
10.2.1 Gedeon Richter Company Information
10.2.2 Gedeon Richter Introduction and Business Overview
10.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Gedeon Richter Inosine Pranobex Products Offered
10.2.5 Gedeon Richter Recent Development
10.3 Mochida
10.3.1 Mochida Company Information
10.3.2 Mochida Introduction and Business Overview
10.3.3 Mochida Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mochida Inosine Pranobex Products Offered
10.3.5 Mochida Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Inosine Pranobex Products Offered
10.4.5 Sanofi Recent Development
10.5 Andrómaco
10.5.1 Andrómaco Company Information
10.5.2 Andrómaco Introduction and Business Overview
10.5.3 Andrómaco Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Andrómaco Inosine Pranobex Products Offered
10.5.5 Andrómaco Recent Development
10.6 Yung Shin
10.6.1 Yung Shin Company Information
10.6.2 Yung Shin Introduction and Business Overview
10.6.3 Yung Shin Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Yung Shin Inosine Pranobex Products Offered
10.6.5 Yung Shin Recent Development
10.7 Alfasigma S.p.A.
10.7.1 Alfasigma S.p.A. Company Information
10.7.2 Alfasigma S.p.A. Introduction and Business Overview
10.7.3 Alfasigma S.p.A. Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Alfasigma S.p.A. Inosine Pranobex Products Offered
10.7.5 Alfasigma S.p.A. Recent Development
10.8 Polfarmex
10.8.1 Polfarmex Company Information
10.8.2 Polfarmex Introduction and Business Overview
10.8.3 Polfarmex Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Polfarmex Inosine Pranobex Products Offered
10.8.5 Polfarmex Recent Development
10.9 Sanfer
10.9.1 Sanfer Company Information
10.9.2 Sanfer Introduction and Business Overview
10.9.3 Sanfer Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanfer Inosine Pranobex Products Offered
10.9.5 Sanfer Recent Development
10.10 Meprofarm
10.10.1 Meprofarm Company Information
10.10.2 Meprofarm Introduction and Business Overview
10.10.3 Meprofarm Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Meprofarm Inosine Pranobex Products Offered
10.10.5 Meprofarm Recent Development
10.11 Novell Pharmaceutical
10.11.1 Novell Pharmaceutical Company Information
10.11.2 Novell Pharmaceutical Introduction and Business Overview
10.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Novell Pharmaceutical Inosine Pranobex Products Offered
10.11.5 Novell Pharmaceutical Recent Development
10.12 Aflofarm
10.12.1 Aflofarm Company Information
10.12.2 Aflofarm Introduction and Business Overview
10.12.3 Aflofarm Inosine Pranobex Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Aflofarm Inosine Pranobex Products Offered
10.12.5 Aflofarm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Inosine Pranobex Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Inosine Pranobex Industrial Chain Analysis
11.4 Inosine Pranobex Market Dynamics
11.4.1 Inosine Pranobex Industry Trends
11.4.2 Inosine Pranobex Market Drivers
11.4.3 Inosine Pranobex Market Challenges
11.4.4 Inosine Pranobex Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Inosine Pranobex Distributors
12.3 Inosine Pranobex Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
